SPS
ALXO icon

Susquehanna Portfolio Strategies’s ALX Oncology ALXO Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,161
Closed -$47.6K – 34
2024
Q3 		$47.6K Sell
26,161
-47,307
-64% -$176K ﹤0.01% 341
2024
Q2 		$443K Sell
73,468
-17,489
-19% -$215K 0.02% 375
2024
Q1 		$1.01M Hold
90,957
– – 0.02% 456
2023
Q4 		$1.35M Buy
+90,957
New +$863K 0.02% 530

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Susquehanna Portfolio Strategies's ALXO Position: Q4 2024 in Review

Susquehanna Portfolio Strategies sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 26,161 shares — an estimated $47.6K sold.

Susquehanna Portfolio Strategies first reported a position in ALXO in Q4 2023 and held it in 4 quarters. The position peaked at $1.35M in Q4 2023. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • Susquehanna Portfolio Strategies reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 26,161 ALX Oncology shares in Q4 2024, an estimated $47.6K.
  • Susquehanna Portfolio Strategies first reported a position in ALX Oncology in Q4 2023 and held it in 4 quarters.
  • Susquehanna Portfolio Strategies's ALX Oncology position peaked at $1.35M in Q4 2023.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.